Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGM-101 and ICG for Fluorescence-guided Resection of Colorectal Liver Metastases
NCT05965817Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2023
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of sgm-101 in colorectal liver metastases (CRLM), sponsored by Leiden University Medical Center. Started Dec 2023; status: recruiting.
02
Drugs
sgm-101
03
Conditions
colorectal liver metastases (CRLM)
Beyond the preview
Go deeper on NCT05965817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05965817.